PortfoliosLab logoPortfoliosLab logo
SIVR vs. FMED
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SIVR vs. FMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in abrdn Physical Silver Shares ETF (SIVR) and Fidelity Disruptive Medicine ETF (FMED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SIVR achieves a -1.40% return, which is significantly higher than FMED's -4.75% return.


SIVR

1D
3.51%
1M
-8.06%
YTD
-1.40%
6M
9.35%
1Y
92.86%
3Y*
42.25%
5Y*
20.46%
10Y*
14.57%

FMED

1D
0.90%
1M
7.10%
YTD
-4.75%
6M
-6.17%
1Y
8.53%
3Y*
0.73%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SIVR vs. FMED - Yearly Performance Comparison


2026 (YTD)202520242023
SIVR
abrdn Physical Silver Shares ETF
-1.40%145.34%21.08%-2.23%
FMED
Fidelity Disruptive Medicine ETF
-4.75%9.69%2.29%-3.59%

Correlation

The correlation between SIVR and FMED is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Jun 12, 2023

0.19

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SIVR vs. FMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SIVR
SIVR Risk / Return Rank: 4444
Overall Rank
SIVR Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
SIVR Sortino Ratio Rank: 3939
Sortino Ratio Rank
SIVR Omega Ratio Rank: 5454
Omega Ratio Rank
SIVR Calmar Ratio Rank: 4545
Calmar Ratio Rank
SIVR Martin Ratio Rank: 3333
Martin Ratio Rank

FMED
FMED Risk / Return Rank: 1515
Overall Rank
FMED Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
FMED Sortino Ratio Rank: 1616
Sortino Ratio Rank
FMED Omega Ratio Rank: 1515
Omega Ratio Rank
FMED Calmar Ratio Rank: 1414
Calmar Ratio Rank
FMED Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SIVR vs. FMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for abrdn Physical Silver Shares ETF (SIVR) and Fidelity Disruptive Medicine ETF (FMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SIVRFMEDDifference
Sharpe ratioReturn per unit of total volatility

+1.12

Sortino ratioReturn per unit of downside risk

+1.06

Omega ratioGain probability vs. loss probability

1.31

1.09

+0.22

Calmar ratioReturn relative to maximum drawdown

2.06

0.47

+1.59

Martin ratioReturn relative to average drawdown

4.44

1.03

+3.40

SIVR vs. FMED - Sharpe Ratio Comparison

The current SIVR Sharpe Ratio is 1.56, which is higher than the FMED Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of SIVR and FMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SIVR vs. FMED - Drawdown Comparison

The maximum SIVR drawdown since its inception was -75.85%, which is greater than FMED's maximum drawdown of -21.84%. Use the drawdown chart below to compare losses from any high point for SIVR and FMED.


Loading charts...

Drawdown Indicators


SIVRFMEDDifference

Max Drawdown

Largest peak-to-trough decline

-75.85%

-21.84%

-54.01%

Max Drawdown (1Y)

Largest decline over 1 year

-45.33%

-18.33%

-27.00%

Max Drawdown (3Y)

Largest decline over 3 years

-45.33%

-21.84%

-23.49%

Max Drawdown (5Y)

Largest decline over 5 years

-45.33%

Max Drawdown (10Y)

Largest decline over 10 years

-45.33%

Current Drawdown

Current decline from peak

-39.85%

-10.64%

-29.21%

Average Drawdown

Average peak-to-trough decline

-47.83%

-7.09%

-40.74%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.00%

8.27%

+12.73%

Volatility

SIVR vs. FMED - Volatility Comparison

abrdn Physical Silver Shares ETF (SIVR) has a higher volatility of 16.52% compared to Fidelity Disruptive Medicine ETF (FMED) at 7.50%. This indicates that SIVR's price experiences larger fluctuations and is considered to be riskier than FMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SIVRFMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.52%

7.50%

+9.02%

Volatility (6M)

Calculated over the trailing 6-month period

59.14%

15.01%

+44.13%

Volatility (1Y)

Calculated over the trailing 1-year period

59.96%

19.37%

+40.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.53%

18.57%

+17.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.05%

18.57%

+13.48%

SIVR vs. FMED - Expense Ratio Comparison

SIVR has a 0.30% expense ratio, which is lower than FMED's 0.50% expense ratio.


Dividends

SIVR vs. FMED - Dividend Comparison

Neither SIVR nor FMED has paid dividends to shareholders.


PositionTTM20252024
FMED
Fidelity Disruptive Medicine ETF
0.00%0.00%0.46%
SIVR
abrdn Physical Silver Shares ETF
0.00%0.00%0.00%

Frequently Asked Questions


SIVR and FMED have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SIVR has higher volatility (16.52%) compared to FMED (7.50%). In terms of maximum drawdown, SIVR dropped -75.85% vs FMED's -21.84%.

On 3-year performance, SIVR leads with 42.25% vs 0.73% for FMED. On fees, SIVR is cheaper at 0.30% per year. On volatility, FMED has been the lower-risk option at 7.50%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, SIVR has performed better with a 42.25% return vs 0.73%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

SIVR is cheaper with a 0.30% expense ratio, compared with 0.50% for FMED.

SIVR and FMED have nearly identical dividend yields, around 0.00%.

SIVR is categorized as Silver, while FMED is Health & Biotech Equities. They also come from different issuers: abrdn and Fidelity. Their fees differ too: 0.30% for SIVR and 0.50% for FMED.

SIVR currently has the higher Sharpe Ratio (1.56 vs 0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SIVR and FMED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer